Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2023   24,850,261      
Beginning balance at Dec. 31, 2023 $ 14,652,295 $ 24,850 $ 57,601,402 $ (42,879,656) $ (94,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 44,535   44,535    
Net (loss) income (1,087,616)     (1,104,967) 17,351
Ending balance (shares) at Mar. 31, 2024   24,850,261      
Ending balance at Mar. 31, 2024 $ 13,609,214 $ 24,850 57,645,937 (43,984,623) (76,950)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock, par value $ 0.001        
Common stock, par value $ 0.001        
Beginning balance (shares) at Dec. 31, 2024   24,950,261      
Beginning balance at Dec. 31, 2024 $ 10,125,538 $ 24,950 57,845,289 (47,639,894) (104,807)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (shares)   35,000      
Exercise of stock options 38,500 $ 35 38,465    
Stock based compensation expense 40,833   40,833    
Distributions to non-controlling interest (32,889)       (32,889)
Net (loss) income (660,489)     (659,922) (567)
Ending balance (shares) at Mar. 31, 2025   24,985,261      
Ending balance at Mar. 31, 2025 $ 9,511,493 $ 24,985 $ 57,924,587 $ (48,299,816) $ (138,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock, par value $ 0.001